SHPH insider trading
NasdaqCM HealthcareShuttle Pharmaceuticals Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Company website: www.shuttlepharma.com
SHPH insider activity at a glance
FilingIQ has scored 19 insider transactions for SHPH since Dec 29, 2022. The most recent filing in our index is dated Jul 1, 2026.
Across the full history, 3 open-market purchases
and 12 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SHPH insider trades is 57.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SHPH?
- FilingIQ tracks 19 Form 4 insider transactions for SHPH (Shuttle Pharmaceuticals Holdings, Inc.), covering filings from Dec 29, 2022 onwards. 3 of those were filed in the last 90 days.
- Are SHPH insiders net buyers or net sellers?
- Across the full Form 4 history for SHPH, 3 transactions (16%) were open-market purchases and 12 (63%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SHPH insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is SHPH in?
- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $2.01M.
Methodology & sources
Every SHPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.